INTRODUCTION
Significant attention has been directed toward research in the general area of stem cells. Although the level of activity is high, there is considerable confusion and disagreement among investigators as to the properties of stem cells. Part of the confusion can be traced to the different definitions that are used to define stem cells, the methods and procedures used to characterize the starting population, and the state of populations of cells that are evaluated. In this review, we first take an historical perspective, emphasizing the rationale for the requirement of clonogenic assays in defining a stem cell, with special reference to the hematopoietic system. We next describe how this approach can be extended to other lineages such as nervous system tissues. With this background, we take up a current area of controversy in stem cell biology-that of transdifferentiation and/or dedifferentiation-and describe how a clonogenic approach to stem cell identification can help to defuse or untangle the current debate.
HEMATOPOIETIC STEM CELLS AS THE MODEL
Stem cells are currently defined as single cells that are clonal precursors of both more stem cells of the same type, as well as a defined set of differentiated progeny (for reviews, see Gage 2000; Weissman 2000a,b) . The first genetic evidence that stem cells exist came from the studies of Till, McCulloch, Wu, Becker, and Siminovitch on blood-forming (hematopoietic) stem and progenitor cells (Till & McCulloch 1961) . In these experiments, random chromosome markers were generated in donor bone marrow by radiation, and colonies of progeny cells, each derived from a single clonogenic precursor, were found in the spleens of conditioned hosts; these colonies always contained differentiated cells of the myeloerythroid series and often contained cells that could be used to reconstitute secondary hosts to produce all blood cell lineages (Becker et al. 1963 , Wu et al. 1968 . Although the concept of stem cells has been extended to many other tissues, it is our contention that only rarely have stem cells been identified as clonogenic precursors that include in their progeny both self-renewed stem cells and differentiated progeny. Just as genetics provides evidence for the nature of a particular event, it does not provide for the purification of the gene, the gene product, or in this case the stem cell that genetic evidence implied. Although biochemistry is the discipline that has provided purification of genes and molecules, a new field of cellular purification was required to allow the prospective isolation of stem and progenitor cells.
To provide for the first isolation of mouse hematopoietic stem cells (HSC), it was necessary to develop assays for the clonal precursors of all known differentiated blood cell types, including myeloerythroid cells (Till & McCulloch 1961) , B lineage cells (Muller-Sieburg et al. 1986 , Whitlock et al. 1987 , and T lineage cells (Ezine et al. 1984) . The second step required for the isolation of HSC was the production of monoclonal antibodies to cell surface molecules found on bone marrow cells. The third requirement was for high-speed sorting of cells bearing and lacking combinations of monoclonal antibody-defined surface determinants (Muller-Sieburg et al. 1986 , Spangrude et al. 1988 ).
An important step in the isolation of HSC was the finding that the clonogenic precursors in all three of the above assays were contained within the population of cells that lacked or had only very low levels of markers of lineage commitment to various blood cell types (Muller-Sieburg et al. 1986 ). Thus HSC are lineage negative (Lin − ) for markers found on T cells, B cells, granulocytes, monocytes/macrophages, erythroid cells, natural killer cells, etc. Mouse HSC are positive for two cell surface glycophosphatidyl inositol-linked immunoglobulin superfamily molecules, Sca-1 (Ly6A/E) and Thy-1 (Spangrude et al. 1988) . They are also positive for the c-kit receptor tyrosine kinase (Ikuta & Weissman 1992) , although in instances in which endogenous or exogenous c-kit ligand (SLF) is abundant, the c-kit marker is partially down-modulated. These c-kit
, bone marrow (BM) cells are, at the clonal level, all multipotent, but can be subdivided into three subpopulations by surface markers and by degree of self-renewal (Morrison & Weissman 1994) : (a) The totally Lin − subset (many but not all of which are CD34 lo ) consists of perpetually self-renewing long-term (LT) HSC. (b) The Mac-1 lo subset of KTLS cells is a uniform population of multipotent cells that self-renew in vivo upon transplantation for ∼6 weeks, which is the end of their productive lifespan (ST-HSC). (c) The Mac-1 lo CD34 lo subset of KTLS are clonogenic multipotent precursors whose self-renewal potential is short and, under transplant conditions difficult to detect; these cells are called multipotent progenitors (MPP). LT-HSC give rise to ST-HSC, which in turn give rise to MPP, and we cannot detect dedifferentiation in that lineage (Morrison et al. 1997a) . That is, ST-HSC never give rise to LT-HSC, and MPP never give rise to either LT-HSC or ST-HSC. KTLS cells can be mobilized from BM to blood; treatment of a donor with cytoxan plus G-CSF causes all HSC to enter the cell cycle, and many daughter HSCs are released to the blood (Morrison et al. 1997b) .
KTLS cells are the only cells within mouse BM that will both radioprotect and reconstitute all blood cell lineages (Uchida & Weissman 1992) . Increasing the dose of KTLS cells transplanted into lethally irradiated hosts shortens the time to the appearance of donor-derived blood cells and elements; however, in the syngeneic (transplant of cells between mice of the same strain) setting, increasing the dose even 10-fold above that required for engraftment by 10 days neither shortens the time to engraftment further nor has any attendant toxicities (Uchida et al. 1998) . These experiments provide two important points for the kind of regenerative medicine that will result from stem cell therapies; first, only stem cells (even LT-HSC) are required for rapid engraftment and, second, the body regulates the cellular output from transplanted HSC. Even in lethally irradiated mice there are immune barriers to the transplantation of HSC from genetically different, allogeneic donors. For example, the minimal HSC dose to just radioprotect 95% of irradiated hosts is 100 cells in the syngeneic setting, about 500 cells in major histocompatibility complex (MHC) -matched but otherwise unmatched donorrecipient combinations, and 1-3000 HSC in a variety of donor host combinations that are neither MHC nor otherwise matched (Shizuru et al. 1996) . Because HSC lack contaminating T lymphocytes, these allogeneic chimeras do not suffer the consequences of a T cell-mediated graft versus host (GvH) response (Shizuru et al. 1996) . These allogeneic chimeras are also specifically tolerant for the life of organ, tissue, or other tissue-specific stem cell transplants from the HSC genotype donor (Gandy & Weissman 1998 , Shizuru et al. 2000 .
Human HSC have been isolated from umbilical cord blood, fetal liver, fetal bone marrow, adult bone marrow, and mobilized peripheral blood (MPB). These cells are CD34
+ , Thy-1 (Negrin et al. 2000) . Successful transplantation of cancer-depleted or cancer-deficient MPB HSC has resulted in donor-derived rescue of fully myelo-ablated cancer patients (stage IV breast cancer, non-Hodgkin's lymphoma, multiple myeloma) in the same dose-dependent fashion that KTLS cells provided in mouse studies (Michallet et al. 2000 , Negrin et al. 2000 .
IDENTIFICATION AND ISOLATION OF HEMATOPOIETIC PROGENITOR CELLS
The same methodology that allowed prospective isolation of mouse HSC has been used to identify and isolate mouse hematopoietic oligolineage progenitors (Akashi et al. 2000 , Kondo et al. 1997 . As shown in Figure 1 , downstream of the clonogenic multipotent pool are two developmental choices, either the common myeloid progenitor (CMP) or the common lymphocyte progenitor (CLP). Each of these cell types has been isolated to homogeneity, each is a clonal precursor of a limited subset of progeny, and each has a distinct expressed gene profile (Akashi et al. 2000; Metcalf 1989 Metcalf , 1991 . Two kinds of cytokine cell surface receptors are good markers of the commitment to the myeloid or the lymphoid pathway: CMP, like HSC, express granulocyte macrophage cell-stimulating factor receptors (GM-CSFR) and do not express cell surface IL-7 receptor, whereas CLP express cell surface IL-7Rαγ c but do not express GM-CSFR (Kondo et al. 1997) . Each CMP can give rise to even more lineage-restricted progenitors, either the granulocyte/monocyte progenitor (GMP) or the megakaryocyte/erythrocyte progenitor (MEP). Under normal conditions, these cells are absolutely lineage restricted and upon transplantation do not detectably self-renew (Kondo et al. 1997) . They must, therefore, be derived continually from HSC, and in the steady state, all HSC (including LT-HSC) will enter the cell cycle in a regulated fashion (Cheshier et al. 1999) . For example, 8% of the LT-HSC enter the cell cycle per day at random, whereas higher percentages of ST-HSC, MPP, CLP, and CMP enter the cell cycle each day (Morrison & Weissman 1994 , Kondo et al. 1997 , Akashi et al. 2000 , Cheshier et al. 1999 . The GMP and MEP progeny of CMP are also virtually all in cell cycle (Akashi et al. 2000) . Following a variety of stimuli, all LT-HSC can enter the cell cycle in vivo in largely self-renewing divisions (Morrison et al. 1997b , Wright et al. 2001 . However, in vitro expansion of KTLS HSC and their subsets by self-renewal has not yet been reliably accomplished.
SELF-RENEWAL, STEM CELLS, AND CANCER
It is important to note that long-term self-renewal is limited to LT-HSC in the hematopoietic stem and progenitor pool. Despite intense investigation, genetic control of self-renewal and LT-HSC expansion remains a mystery. It is also important to note that all mouse leukemias, no matter what stage of differentiation marks the leukemogenic stem cell, have also gained the properties of self-renewal, as have all other clonogenic cancer cells. It is crucial, therefore, to define the genetic control of self-renewal in this class of stem cells, as well as the leukemias derived from their progeny.
There are several important points about the fact that normally only stem cells self-renew perpetually and that leukemias and cancers contain leukemic (Bonnet & Dick 1997) and cancer stem cells that have gained (or retained) the property of self-renewal. Several leukemias contain leukemia-specific chromosomal translocations, deletions, amplifications , or inversions (e.g., Miyamoto et al. 2000 , Fialkow et al. 1991 , Seale et al. 1996 , Faderl et al. 1999 , Hagemeijer et al. 1984 . In many of these leukemias, the critical chromosomal aberration is in the HSC pool, varying from a fraction to all HSC. Yet in many of these cases, the HSC are not malignant (Miyamoto et al. 2000) . We have proposed that although in acute myelogenous leukemia the translocation (AML-1; ETO) is in HSC, the final steps in leukemia progression have occurred downstream of HSC (Miyamoto et al. 2000) . This makes sense. If HSC are the only hematopoietic cells that normally self-renew, then the only genetic alterations in leukemia progression that can be retained in the hematopoietic system must accumulate in HSC, until one or more events permit a downstream progenitor class to self-renew. After that, both self-renewing populations can accumulate transforming mutations. The result, presumably true for all malignancies and not just leukemias, is that either the normal stem cell class or a downstream cell (Miyamoto et al. 2000 , Bonnet & Dick 1997 could gain the ultimate stage of malignant progression. In one case, the malignancy is in stem cells, and in the other, a downstream progenitor is transformed to the cancer stem cells.
An additional point is that within a leukemia or a cancer, the cancer stem cell may not exclusively self-renew but may simply increase the frequency of self-renewing divisions. The consequence of this possibility is that the cancer/leukemia stem cell could be a minority of cells in the lesion and in its clone. Given this possibility, it will be essential to identify and isolate the malignant stem cell for each type of malignancy because only this cell has the critical gene expression profile of the true cancer cell or the critical tumor antigens against which effective immunity must be directed.
CENTRAL NERVOUS SYSTEM (CNS) STEM CELLS
Although the conventional wisdom has been that regeneration of brain cells cannot occur after a certain age, the pioneering experiments of Altman (Altman 1962 , Altman & Das 1965 , Alvarez-Buylla (Lois & Alvarez-Buylla 1993 , 1994 , Bartlett (Kilpatrick & Bartlett 1993 , Goldman & Nottebohm (1983) , and Gage (Gage 2000, Kuhn et al. 1997 , Kempermann et al. 1997 , Eriksson et al. 1998 ) have demonstrated regions of continued high-rate neurogenesis throughout life in rodents and humans. These regions include the subventricular zones (SVZ) bordering (at least) the lateral ventricles and the dentate gyrus (DG) in the hippocampus (Gage 2000). Although it is conceivable that low-rate proliferation might occur in adult brains in different regions, the evidence is not yet in. The methodologies that led to an understanding that CNS stem cells must exist and therefore could be prospectively isolated began with the demonstration that cells derived from rodent fetal brain or adult SVZ or adult DG cells can grow in vitro in the presence of defined factors such as bFGF and EGF (Reynolds & Weiss 1992 , Richards et al. 1992 , Temple & Alvarez-Buylla 1999 , Temple & Davis 1994 , Gritti et al. 1996 , Johe et al. 1996 , Kalyani et al. 1997 , Mayer-Proschel et al. 1997 , Ray et al. 1993 , Davis & Temple 1994 . These cells can grow as adherent monolayers or as non-surface adherent but self-associating neurospheres (Reynolds & Weiss 1992 , Temple & Alvarez-Buylla 1999 , Temple & Davis 1994 , Gritti et al. 1996 , Ray et al. 1993 , Davis & Temple 1994 . Embryonic stem (ES) cell cultures have been used as a source of subsets of CNS-committed cultures (Brustle et al. 1998 (Brustle et al. , 1999 . Retroviral marking of adherent rodent brain cell cultures revealed the presence of clonally marked cells that can both self-renew and give rise to neurons, astrocytes, and oligodendrocytes (Palmer et al. 1997) . Transplantation of these clonally marked rodent brain cell cultures into the hippocampus or into the subventricular zone (SVZ) or even into the newborn rat eye has revealed that these cells might include a population of CNS stem cells capable of responding to local microenvironmental cues (Gage 2000; Brustle et al. 1998 Brustle et al. , 1999 Flax et al. 1998; Morshead et al. 1994; Johansson et al. 1999; Snyder 1994; Reynolds & Weiss 1996) . When it was found that human fetal brain cells could also respond to these growth factors by forming neurosphere cultures (Carpenter et al. 1999) , the possible existence of a neurosphere-initiating stem cell was proposed (Uchida et al. 2000) . Using the same methodologies of clonogenic assays (the neurosphere-initiating cells), i.e., the production and use of cell surface monoclonal antibodies to cell surface determinants and high-speed fluorescent-activated cell sorting (FACS), led to prospective isolation of candidate human fetal brain CNS stem cells (Uchida et al. 2000) . Neurospheres derived from CD133
+ , CD24
−/lo , CD34 − , CD45 − c-kit − candidate CNS stem cells could be dissociated and transplanted into the lateral ventricles of genetically immunodeficient newborn NOD-SCID mice (Uchida et al. 2000) . The newborn mouse brain is obviously still undergoing much neurogenesis, and so one could hope that the engrafted cells would participate in such neurogenesis. In fact, robust engraftment was seen for the life of the recipients. In both the SVZ and DG, even 7 months later, human cells, similar to their mouse counterparts, were significantly engaged in continued cell proliferation evidenced by their expression of the proliferationspecific marker Ki67. In zones where mouse cells were migrating away from the sites of proliferation, human cells were found for as long as 7 months or more, where they could be followed, differentiating en route. In zones where mouse cells had differentiated into neurons and glia, human cells also showed morphological evidence of having differentiated into neurons and glia. Standard histological examination of these chimeric mouse brains showed no easily detectable abnormalities such as proliferative or neoplastic cell foci or mal-development. In addition, the progeny of these cells could be found throughout the mouse brain, including the corpus callosum, the striatum, the mid-brain, the cerebellum, and even the cerebral cortex. Injection of similar neurospheres into the SVZ or DG of adult immunosuppressed rats had also been shown to result in site-specific and apparently appropriate human cell proliferation, cell migration, and cell differentiation (Fricker et al. 1999) . Gene modification of these adherent cells (Palmer et al. 1997) and neurosphere cultures has been demonstrated; it is reasonable to propose that if gene modification of CNS stem cells in vitro leads to appropriately regulated gene expression upon transplantation, this will add a potent new tool to the armamentarium of stem cell biologists, developmental biologists, and neurobiologists who wish to study the development and function of rodent and human brain cells (reviewed in Anderson 2001) . It also is to be expected that by using the techniques described above for the identification of downstream hematopoietic oligolineage progenitors, one should be able to begin to identify and place in lineages both human and rodent CNS progenitors of the major lineages and sublineages.
IDENTIFICATION AND ISOLATION OF PERIPHERAL NERVOUS SYSTEM (PNS) STEM CELLS
Using in vitro assays for the outcome of differentiation of neural crest cells, Anderson et al. sought the phenotype of PNS stem cells (Stemple & Anderson 1992) . The vertebrate fetal neural crest gives rise to cells that contribute to all head structures, as well as to the peripheral nervous system, the adrenal medulla, most if not all smooth muscle cells, melanocytes, and the visceral nervous system (Anderson et al. 2001) . Cultured populations of neural crest-derived cells contained a subset of P75 + PO − PNS stem cells capable of multilineage maturation. Such cells could be prospectively isolated from the fetal neural crest as well as from late fetal tissues, such as rodent sciatic nerve, using similar markers, and could be shown to be self-renewing clonogenic precursors of peripheral neurons, glia (Schwann cells), and smooth muscle cells (Morrison et al. 1999) . Amazingly, rat PNS-SC can be transplanted to chick embryos, where they retain their PNS developmental fates, apparently in response to microenvironmental cues that may be evolutionarily conserved (White & Anderson 1999 , White et al. 2001 . Instructive differentiation factors for each of these differentiated derivatives have been identified: GMP2 for autonomic neurons, TGFβ for smooth muscle cells, and Nrg-1 and Notch for Schwann cells (Shah et al. 1994 (Shah et al. , 1996 Shah & Anderson 1997; Morrison et al. 2000) . It is not clear whether such neural crest stem cells can give rise to all classes of PNS neurons, e.g., sensory as well as autonomic neurons. Similarly, it is not clear whether multipotent CNS progenitors of neurons, astrocytes, and oligodendrocytes can generate all classes of CNS neurons.
TRANSDIFFERENTIATION (TRANSDETERMINATION?) OF STEM AND PROGENITOR CELLS
Many recent publications have claimed direct demonstration of transdifferentiation of cells of one type of commitment to stem cells or differentiated cells for distinct organs or tissues (Ferrari et al. 1998; Bjornson et al. 1999; Gussoni et al. 1999; Gritti et al. 1996; Clarke et al. 2000; Brazelton et al. 2000; Mezey et al. 2000; Pereira et al. 1995; Petersen et al. 1999; Theise et al. 2000a,b) . Before we examine these data more closely, it is important to establish the minimum criteria for transdifferentiation of stem cells (Morrison 2000; Anderson et al. 2001) . Stem cells are clonogenic cells capable of self-renewal and differentiation. Any claim for transdifferentiation must begin with clonally identified tissue-specific stem cells and end with isolation of stem cells, progenitor cells, and progeny in the transdifferentiated organ or tissue. Unfortunately, a jargon exists in both the clinical and scientific literature that equates bone marrow or mobilized peripheral blood or umbilical cord blood transplants with HSC transplants. Similarly, a number of investigators define neurospheres as stem cells without demonstrating that there are any stem cells that can be prospectively isolated and then further assume that every cell in the sphere is a stem cell when it is not clear what frequency are stem cells. The BM, a complex tissue, contains a variety of cell types that include cells committed to mesenchymal lineages (Pittenger et al. 1999 ), others to endothelial outcomes, and still others to hematopoietic outcomes. Thus it is possible to unwittingly have stem cells of one type of tissue, when in fact they could be stem cells from another tissue or cells that are not stem cells at all but have undergone limited morphological differentiation similar to cell types in the host organ (Figure 2) . We believe that a claim of stem cell differentiation should include marking or isolating prospectively the cell from the donor tissue and demonstrating, at the clonal level, that this a stem cell from the donor, and that such cells have the capacity to repopulate and regenerate stem cells, oligolineage progenitors, and differentiated and functional progeny. It is not sufficient that rare progeny take on the morphological appearance of tissue-specific differentiated cells. It is not sufficient if the repopulating unit is not shown to be a clonogenic stem cell rather than a cluster of interacting yet heterogeneous cells. Given these requirements and the examples described in the legend in Figure 2 , it is now appropriate to consider whether stem and/or progenitor cells can be caused to transdifferentiate.
A Progenitor Cell Switch
Transplantation of mouse CLP into irradiated hosts reveals their ability only to produce all varieties of T cells, B cells, natural killer (NK) cells, and antigen-presenting dendritic cells that do or do not express or express surface CD8α (Traver et al. 2000) . Adult BM CLP have never been shown either in vitro or in vivo to give rise to granulocytes or macrophages (Kondo et al. 1997 ). However, if one induces in or transfects to CLP, the GM CSF receptor, or genes that can induce the expression of that receptor, these cells can immediately respond by differentiating to granulocytes and macrophages at the expense of generating lymphoid cells, even at the clonal level (Kondo et al. 2000) . While this may seem to be a limited transdifferentiation, it is important to note that the morphological, functional, and gene expression profiles of granulocytes and independently of macrophages are dramatically different from those of the above-described lymphoid progeny. Interestingly, culture of CLP in the presence of the lymphoid-specific cytokine IL-7 can, after several days, render them resistant to the rescued transdifferentiation to GM cells (Kondo et al. 2000) . During that process, most of these cells in vitro commit to the B cell lineage (Kondo et al. 1997 (Kondo et al. , 2000 . Freshly isolated early pro-B cells cannot be transdifferentiated to GM cells, although very early pro-T cell types in the thymus can (Kondo et al. 2000) . At the stage of thymic T cell differentiation that correlates to the rearrangement and surface expression of antigen-specific TCRαβ heterodimers, the cells have become resistant to transdifferentiation to GM cells (A. King, M. Kondo & I.L. Weissman, in preparation). It appears, therefore, that in normal lineage commitments a phase of lymphoid-specific determination exists wherein the normal outcomes are only of the lymphoid type, but the genome remains sufficiently plastic for further developmental stages to be rescued from one set of phenotypes to another. This might be a general principle.
Another Proposed Case of Transdifferentiation from Known Progenitor Cells
In rodents, a class of glial progenitors can be isolated from the optic nerve that normally have the ability to produce only oligodendrocytes and some astrocytes (Kondo & Raff 2000) . However, when these O2A cultures are exposed to BMP2 or 10% fetal calf serum and then switched into the type of culture medium that enables the development of neurospheres, these cells, too, can give rise to neurospheres that generate neurons, astrocytes, and oligodendrocytes (Kondo & Raff 2000) . However, in this experiment, it remains possible that a rare subpopulation of bFGF-responsive uncommitted cells are responsible for the trilineage outcome.
A Case of Transdifferentiation of Prospectively Isolated Hematopoietic Stem Cells to Liver in Adults Undergoing Induced Liver Degeneration and Regeneration
Mice bearing the most common class of mutations found in human hereditary tyrosinemia patients [inactivation of fumaryl acetoacetic hydrolase (FAH)] usually undergo progressive cycles of liver degeneration, regeneration, and the development of hepatocarcinomas (Grompe et al. 1995) . This is almost certainly the result of build-up of the tyrosine catabolites succinyl acetoacetic acid and fumaryl acetoacetic acid, which are toxic to both liver and kidney proximal tubules (Grompe et al. 1995) . Placing these mice on a tyrosine-free diet and providing them with a drug (NTBC) that blocks the first step of catabolism of tyrosine allows these transgenic mutant mice to survive (Grompe et al. 1995) . Reintroduction of a tyrosine-containing diet along with withdrawal of NTBC leads to programmed liver degeneration and death from hepatic failure (Grompe et al. 1995) . KTLS HSC from FAH + LacZ + male CD45 congenic donors were transplanted at limit dilution or at high-cell doses into lethally irradiated FAH − hosts; in the limit dilution case, mice were rescued from hematopoietic failure with female FAH − LacZ − CD45 congenic BM (Lagasse et al. 2000) . These KTLS HSC expressed CD45, a molecule found normally only on all blood-forming cells, except mature erythrocytes, and not found on other cell types in the body. When these mice were later placed on tyrosine-containing diets and withdrawn from NTBC for several cycles, LacZ + Y chromosome-positive FAH + liver nodules made up of albumin-producing E cadherin-positive hepatocytes were found (Lagasse et al. 2000) . Using single-marker depletions and purifications, it was shown that the only cells in mouse BM that could reconstitute donor-derived liver nodules were c-kit Lagasse et al. 2000) . Transplantation of whole BM from FAH + LacZ + male mice not only gave rise to donor-derived liver regeneration, but these mice had restored liver function that kept the hosts alive, even in the absence of NTBC (Lagasse et al. 2000) . Furthermore, the only mice showing donor-derived hepatopoiesis also showed donor-derived hematopoiesis; no instances of donorderived hematopoiesis or hepatopoiesis alone were recorded (Lagasse et al. 2000) . Although the limit dilution experiments here imply that a single clonogenic HSC can in this circumstance give rise to both blood and liver, these experiments need to be carried out with either single-cell KTLS HSC transplants or with randomly marked KTLS cells.
In this case of liver regeneration, one can say with confidence that KTLS HSC, presumably cells of mesodermal origin, regenerate liver epithelial cells, presumably of endodermal origin. This brings up the question of what is the normal source of liver stem cells during fetal development-KTLS HSC or endodermalcommitted cells? Although it has been demonstrated that endodermal buds transplanted reciprocally between same developmental stage quail and chicks can give rise to donor-derived liver and pancreas, it is not clear whether the stem cell within these endodermal buds are not HSC. In a classic case similar to this one, using fetal thymic transwell cultures, early fetal thymic epithelium cultured with same age thymic or non-thymic mesenchyme produced thymic lymphocytes in the epithelial side (Auerbach 1961) . However, later studies demonstrated that within similar dissociated thymic epithelia recently emigrated rare cells of hematopoietic appearance were found and that it was these cells rather than the much more abundant epithelial cells that gave rise to thymic lymphocytes (Moore & Owen 1967) . Rigorous purification of cells in the early embryonic endodermal region must be attempted in order to identify the nature of the cell type or types in the bud that gives rise to the first liver and pancreas cells.
These experiments call into question what we think we know about the embryonic/fetal generation of each organ or tissue and whether the same or different cell types remain for the regeneration of such cells and tissues. Given the robust transdifferentiation capacity of KTLS HSC in at least this case, one must wonder whether KTLS HSC or another multipotent cell is responsible for other reports of transdifferentiations or even of organism cloning from nuclei. Relevant to this proposal is the recent demonstration that MPB KTLS HSC are present in the blood with a residence time of 1-5 min (Wright et al. 2001; A. Wagers, D. Wright & I.L. Weissman, in preparation) . Because several hundred KTLS HSC can be found in normal blood at any time, it is apparent that continual flux of large numbers of HSC from bone marrow to blood to tissues may be occurring every day. Thus isolation of cells from muscle, liver, mammary gland, or even brain must be considered to be potentially contaminated with KTLS HSC. Low-frequency readouts of tissue transdifferentiation or donor nucleus-derived organism cloning might therefore derive not from most resident cells in the tissue but from a rare set of pluripotent or multipotent cells passing through that tissue.
Several other demonstrations of apparent transdifferentiation have been recorded. Perhaps most striking is the demonstration that single cell-derived neurospheres, when transplanted into genetically distinct mouse blastocysts or even into early chick embryos, at very low frequency, give rise to a wide variety of epithelial tissues (Clarke et al. 2000) . In another example, neurospheres bearing clonal retroviral markers upon transplantation into sublethally irradiated, fully allogeneic mouse recipients resulted incredibly in a late switch of all hematopoiesis from host to donor (Bjornson et al. 1999 ). Both of these remarkable experiments should be repeated by independent laboratories, much in the way the KTLS HSC to liver transdifferentiation should be repeated by independent laboratories.
In another striking experiment, partially enriched Lin − Sca-1 + hematopoietic cells transplanted directly into the dying myocardium of recipients, in which 3-5 h previously the left anterior descending coronary arteries had been ligated, resulted in robust regeneration of myocardium, endothelium, and endothelial smooth muscle cells from the donor (Orlic et al. 2001 ). It will be critical to test whether the Lin − Sca + BM cells responsible for these regenerations are HSC or some other Lin − Sca + cells, of which there are many types in BM. In many tissues, a rare subset of cells capable of excluding organic dyes such as rhodamine 123 or Hoechst 33342 from cell cytoplasm (called the side population) can be prospectively isolated and shown to be enriched for progenitors for blood formation or for muscle regeneration (Goodell et al. 1996) . The BM side population appears to be highly enriched for, but not entirely composed of, KTLS HSC (Goodell et al. 1996) . Side population cells from BM have been reported to regenerate muscle and side population muscle cells to regenerate blood (Gussoni et al. 1999 , Jackson et al. 1999 . It remains to be determined whether these are cells committed normally to that organ's regeneration, or in the case of muscle origin, are these hematopoietic CD45 + cells and myogenic CD45
There are many reports of unseparated BM cells that have generated rare cells in the brain or the blood vessels. In these cases, the identity of the cells within the BM responsible for the transdifferentiation is not known, nor are the daughter cells found in different organs yet shown to have functional characteristics of resident mature cells in these organs. Much remains to be done with these types of experimental models.
CONCLUSION
The advent of stem cell biology has revealed several unexpected principles, including the likelihood that most if not all tissues are generated during fetal life and regenerated in adult life from stem to progenitor to progeny cells. The application of stem cell biology to clinical hematopoietic cell transplantation has allowed massive expansion of the disease indications for such stem cell transplantations, either autologous or allogeneic, in preclinical animal models. Stem cell biology has been applied to human hematopoietic cell transplantation as well, wherein the goal is to allow the physician to use lethal doses of myeloablative drugs in an attempt to kill all endogenous cancer cells thereby rescuing the patients with cancer free HSC. The recent flurry of papers claiming adult regeneration of non-hematopoietic tissues and transdifferentiation and regeneration in these tissues provides great promise that these too will be translated into clinical therapies. But we must require that both the scientists and the translators of such science to clinical medicine refrain from using confusing jargon and that they must be as rigorous in substantiating their claims of stem cell isolation and stem cell transdifferentiation as the highest standard used by fundamental stem cell biologists.
Visit the Annual Reviews home page at www.AnnualReviews.org forebrain and cerebellum, and they differ Figure 1 Proposed model of major hematopoietic maturation pathways from HSC. Longterm HSC (LT-HSC) give rise to short-term (ST) HSC. We propose that ST-HSC give rise to at least CLP, which can form all cells of the lymphoid lineage, and CMP, which can differentiate into either GMP or MEP, which form the cells of the granulocyte/macrophage or megakaryocyte/erythroid lineages, respectively. The three myeloid progenitor subsets should make up the vast majority of myeloid progenitor activity in steady-state bone marrow because the Sca-1 − c-kit + fraction, which is composed of GMP, MEP, and CMP, and the Sca-1 + c-kit + HSC fraction, were estimated to contain ∼98% of myeloid colony-forming activity within the Lin-IL-7Rα-fraction (data not shown). (From Nature 404: 193-97, 2000 , with permission) 
